Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Exilby®, a First-in-Class Non-Opioid Treatment for Chronic Low Back Pain, Receives Its First European Marketing Authorization from VERTANICAL; Pivotal U.S. Phase 3 Trial Underway

VERTANICAL announced that Exilby® (VER-01) has received marketing authorization in Germany for the treatment of chronic low back pain with a radicular (neuropathic) component. The authorization marks a major milestone for VERTANICAL and highlights...

BEACON Real-World Study Shows Positive Top-Line Results for ZUNVEYL® in Alzheimer’s Disease, Reports Alpha Cognition

Alpha Cognition Inc. a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, announced the top-line results from its BEACON real-world study evaluating provider-reported cognitive, behavioral,...

TrueMed Selected by a Global Top-10 Pharmaceutical Company to Protect Three High-Volume Drug Brands Against Counterfeit Threats

TrueMed, the leader in AI-based pharmaceutical counterfeit detection, today announced a commercial partnership with one of the world's ten largest pharmaceutical companies. The agreement brings TrueMed's AI-powered authentication platform to three...

Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

Beauty Crush Skincare, the latest venture from innovative beauty leader Karen Behnke, debuts and once again introduces formulas that challenge the industry with a new era of regenerative biotechnology-driven skincare. The collection combines a...

Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

Nestlé Health Science, a global leader in the science of nutrition, and IdB Holding S.p.A. (IdB), a global leader in the production of high potent active pharmaceutical ingredients for the pharmaceutical and the health food industries, announced...

Digi-Tech Pharma & AI Conference 2026

The 9th Annual Digi-Tech Pharma & AI conference, a premier Pharmaceutical Technology Conference, brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare...

Lundbeck Receives Marketing Authorization in South Korea for Vyepti® (eptinezumab) for the Preventive Treatment of Migraine

H. Lundbeck A/S (Lundbeck) announced that the Ministry of Food and Drug Safety (MFDS) of South Korea has granted marketing authorization for eptinezumab for use in adults with migraine. Migraine is a progressive and debilitating neurological...

Galvanize Therapeutics receives FDA clearance for the Aliya EX Generator, expanding its Aliya Pulsed Electric Field portfolio

Galvanize Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today announced that it received U.S. Food and Drug Administration 510(k) clearance...

A new real-world case series examines re-induction with ADSTILADRIN in clinical practice

Ferring Pharmaceuticals announced a new real-world case series demonstrating that re-induction with ADSTILADRIN® (nadofaragene firadenovec-vncg) resulted in complete responses (CR) in approximately 31% (4/13) of patients with high-risk Bacillus...

Biohack skin longevity with Futurecode Booster

The concept of biohacking often brings to mind performance tracking and high-tech optimization – but at its core, it's a mindset grounded in understanding how the body functions and supporting it to work more efficiently. From adding collagen to...

Neurocritical care leaders will discuss NPi pupillometry in NeurOptics sessions at AACN NTI 2026.

Two nationally recognized leaders in neurocritical care nursing will join NeurOptics at the upcoming American Association of Critical Care Nurses National Teaching Institute & Critical Care Exposition to discuss the role of NPi® pupillometry in...

SUANNUTRA USA secures U.S. distribution rights for TetraSOD.

Nutraceutical ingredients innovator SUANNUTRA USA announces it has inked a distribution agreement with Spanish biotech company Fitoplancton Marino, S.L. to provide TetraSOD® for the North American market. TetraSOD® is a science-backed bioactive...

MinuteClinic highlights improved access and outcomes through its clinically supervised weight-loss program

As chronic conditions tied to metabolic health continue to rise across the United States, MinuteClinic®, the medical clinic inside select CVS Pharmacy® locations, is highlighting its clinically supervised weight-loss program to support earlier...

BIZENGRI® (Zenocutuzumab-zbco) Wins FDA Approval for NRG1 Fusion-Positive Cholangiocarcinoma, Says Partner Therapeutics

Partner Therapeutics, Inc. (PTx), a private, fully integrated biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has approved BIZENGRI® (zenocutuzumab-zbco) for the treatment of adults with advanced, unresectable or...

Miach Orthopaedics Appoints Jamal Rushdy as President & CEO

Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL. Restoration (BEAR®) Implant, announced Jamal Rushdy has been selected as the...

Avenacy Announces U.S. Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, announced it has launched Tranexamic Acid in 0.7% Sodium Chloride Injection in the United States. The product contains the same active ingredient as...

New Study Suggests 5-MTHF as Effective Alternative to Folic Acid in Later Pregnancy

Women's health supplement brand Ritual in partnership with Brooklyn College (CUNY) announced the publication of the folate results from their clinical trial on their top-selling Essential Prenatal in the journal Frontiers in Nutrition. The...

Viralgen Teams with Elaaj Bio to Advance CDKL5 Deficiency Gene Therapy

Viralgen, a leading contract development and manufacturing organization (CDMO) specializing in recombinant adeno-associated virus (rAAV) gene therapies, announced today a partnership with Elaaj Bio, a biotechnology company focused on development...

BioOra Limited and Wellington Zhaotai Therapies Limited (WZTL) Execute Heads of Terms to Accelerate Global Expansion of CAR T-Cell Therapy

BioOra Limited, a New Zealand-based company pioneering automated, cost-effective CAR T-cell manufacturing, announced the signing of a binding Heads of Terms agreement with Wellingto. Zhaotai Therapies Limited (Wellington Zhaotai) under which...

NurtureBio Launched Breast Milk–Inspired Synbiotic to Help Babies with Gut Issues

NurtureBio, a new maternal and child wellness company focused on emerging scientific solutions to gut health issues, today announced its official launch and the release of its first product: a synbiotic supplement. This synbiotic features human...